Sign in

COAG on Nasdaq

Hemab Therapeutics Holdings, Inc.

Hemab Therapeutics Holdings, Inc. is an American biological products company, incorporated in Delaware.1 It is headquartered in Cambridge, Massachusetts.1 Its shares trade on Nasdaq under the symbol COAG.1

Price unavailable

Last updated Oct 21, 2026.

Overview

Compare with another stock.

  • TickerCOAG on Nasdaq1
  • IndustryBiological Products, (No Diagnostic Substances)1
  • HeadquartersCambridge, Massachusetts1
  • Incorporated inDE2
  • Business address101 Main Street, Suite 1220, Cambridge, Ma 021422
  • Filer category, Emerging growth company2

See how the biggest companies compare on our leaderboards

Corporate structure

Hemab Therapeutics Holdings, Inc. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Hemab Therapeutics Holdings, Inc.

  • Hemab Therapeutics Holdings, Inc. Cambridge, Massachusetts

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

Leadership

Who has led Hemab Therapeutics Holdings, Inc., and when. Pick a name to see everywhere that person has worked.

Chief operating officer

  1. Ananthram Sreenivasa Murthy2026–now
Board members and other officers (11)

Timeline

  1. Sep 24, 20268-K Executive or director change13
  2. Aug 11, 20268-K Results of operations14
  3. May 21, 20268-K Results of operations15
  4. May 11, 20268-K Executive or director change16
  5. May 4, 20268-K Bylaws or fiscal year changed; Other events17

Calendar

Coming up

  1. Nov 10, 2026Reports results for the quarter ending Sep/202618

When it reported results

  1. Aug 11, 2026Reported quarterly or annual results14
  2. May 21, 2026Reported quarterly or annual results15

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

50 filings to the SEC since October 2021: 2 quarterly reports, 5 major events, 22 insider forms, 9 large holders, 12 other. The latest 20:

  1. Sep 25, 20264 EDGAR
  2. Sep 25, 20263 EDGAR
  3. Sep 24, 20268-K EDGAR
  4. Aug 14, 2026SCHEDULE 13G EDGAR
  5. Aug 14, 2026SCHEDULE 13G EDGAR
  6. Aug 12, 2026SCHEDULE 13G EDGAR
  7. Aug 11, 202610-Q EDGAR
  8. Aug 11, 20268-K EDGAR
  9. Aug 7, 2026SCHEDULE 13G EDGAR
  10. Aug 6, 2026SCHEDULE 13G EDGAR
  11. Aug 5, 2026SCHEDULE 13G EDGAR
  12. Jun 17, 20264 EDGAR
  13. May 21, 20264 EDGAR
  14. May 21, 202610-Q EDGAR
  15. May 21, 20268-K EDGAR
  16. May 14, 20264 EDGAR
  17. May 14, 20263 EDGAR
  18. May 11, 2026SCHEDULE 13G EDGAR
  19. May 11, 20264 EDGAR
  20. May 11, 2026SCHEDULE 13D EDGAR

The 50 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

11 open-market trades by officers, directors and large owners since October 2021: 11 buys and 0 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Jun 16, 2026RA CAPITAL MANAGEMENT, L.P.10% ownerBuy61,523$24.98$1.5MForm 4
Jun 15, 2026RA CAPITAL MANAGEMENT, L.P.10% ownerBuy6,146$24.89$153.0KForm 4
May 20, 2026RA CAPITAL MANAGEMENT, L.P.10% ownerBuy996$24.94$24.8KForm 4
May 19, 2026RA CAPITAL MANAGEMENT, L.P.10% ownerBuy3,802$24.97$94.9KForm 4
May 12, 2026Kolchinsky Peter10% ownerBuy6,387$24.90$159.0KForm 4
May 11, 2026RA Capital Healthcare Fund LP10% ownerBuy39,869$24.81$989.2KForm 4
May 8, 2026RA Capital Healthcare Fund LP10% ownerBuy1,483$24.98$37.0KForm 4
May 7, 2026RA Capital Healthcare Fund LP10% ownerBuy9,906$24.46$242.3KForm 4
May 6, 2026Shah Rajeev M.10% ownerBuy68,018$24.60$1.7MForm 4
May 5, 2026Shah Rajeev M.10% ownerBuy97,411$24.63$2.4MForm 4
May 4, 2026Shah Rajeev M.10% ownerBuy2,675,000$18.00$48.1MForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 55. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Ra Capital Management, L.P.7,808,627$286.8M2.5%New
Novo Holdings A/s4,180,550$153.6M8.9%New
Fmr LLC3,697,837$135.8M0.0%New
Capital International Investors3,603,876$132.4M0.0%New
Deep Track Capital, LP3,602,093$132.3M1.9%New
Siren, L.L.C.2,086,834$76.6M1.6%New
Avoro Capital Advisors LLC1,925,150$70.7M0.6%New
Bain Capital Life Sciences Investors, LLC1,650,000$60.6M3.6%New
Jpmorgan Chase & Co1,152,420$42.3M0.0%New
Vanguard Capital Management LLC780,758$28.7M0.0%New
Driehaus Capital Management LLC715,791$26.3M0.2%New
Rock Springs Capital Management LP575,432$21.1M1.0%New
Bellevue Group AG550,000$20.2M0.4%New
Citadel Advisors LLC523,450$19.2M0.0%New
BlackRock, Inc.283,833$10.4M0.0%New
Deerfield Management Company, L.P.275,000$10.1M0.1%New
ExodusPoint Capital Management, LP218,287$8.0M0.1%New
Geode Capital Management, LLC211,798$7.8M0.0%New
Braidwell LP160,000$5.9M0.2%New
Marshall Wace, Llp154,674$5.7M0.0%New
Woodline Partners LP150,040$5.5M0.0%New
Affinity Asset Advisors, LLC138,030$5.1M0.3%New
Ensign Peak Advisors, Inc115,394$4.2M0.0%New
Vanguard Fiduciary Trust Co112,499$4.1M0.0%New
Charles Schwab Investment Management Inc108,236$4.0M0.0%New

13F reports cover disclosed long positions in U.S. stocks only.

SEC filer profile

How Hemab Therapeutics Holdings, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARHemab Therapeutics Holdings, Inc.1
  • CIK0002114044
  • Employer ID (EIN)41-42419521
  • Filer status<br>emerging growth company1
  • Incorporated inDelaware1
  • Fiscal year endsDecember 311
  • Industry code (SIC)2836 Biological Products, (No Diagnostic Substances)1
  • SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
  • Business address101 Main Street, Suite 1220, Cambridge, MA 021421
  • Phone45 2138 76271
  • Shares outstanding46,712,117 as of Jul 31, 202628
  • On EDGAR sinceFeb 27, 20261
  • Filings50 in all: 3 (12), 4 (10), SCHEDULE 13G (8), 8-K (5), S-1/A (3), 10-Q (2), 424B4 (1), 8-A12B (1)1
    All 16 form types

    CERT (1), DRS (1), DRS/A (1), EFFECT (1), S-1 (1), S-1MEF (1), S-8 (1), SCHEDULE 13D (1)

  • Latest filingsQuarterly report (10-Q) Aug 11, 2026
    Latest 8-K (8-K) Sep 24, 2026

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28